CP, June 2018, Vol 10, No 6

No significant difference between LAMAs and LABAs in treating persistent asthma, research finds

Data from 15 randomised trials show that while long-acting muscarinic antagonists reduced exacerbation risk by a third, there was no significant improvement compared with long-acting beta-agonists.…

ACE inhibitors and beta-blockers reduce risk of cardiotoxicity for some Herceptin patients

Researchers conclude that prophylactic use of lisinopril or carvedilol should be considered in patients who could benefit from anthracycline treatment prior to trastuzumab (Herceptin).…

Large study supports use of multimodal pain management after joint replacement

Using data from more than 1.5 million patients who underwent joint replacement surgery, researchers found a stepwise increase in beneficial effects as the number of analgesic modes increased.…